AUGEOZ 1000MG/125MG INJECTION is a combination of two medicines: Cefepime and Tazobactum. Cefepime is an antibiotic. It works by preventing the formation of the bacterial protective covering which is essential for the survival of bacteria in the human body. Tazobactum is a beta-lactamase inhibitor which blocks the action of enzymes produced by bacteria to inactivate cefepime. Addition of Tazobactum reduces resistance and enhances the activity of Cefepime against bacteria.
Interaction with alcohol is unknown. Please consult your doctor.
AUGEOZ 1000MG/125MG INJECTION is probably safe to use during pregnancy. Animal studies have shown low or no adverse effect on the foetus, however, there are limited human studies. Please consult your doctor.
AUGEOZ 1000MG/125MG INJECTION is safe to use during lactation.
Human studies have shown that either the drug does not pass into the breastmilk in significant amount or is not expected to cause toxicity to the baby.
It is not known whether AUGEOZ 1000MG/125MG INJECTION alters the ability to drive. Do not drive if you experience any symptoms that affect your ability to concentrate and react.
AUGEOZ 1000MG/125MG INJECTION should be used with caution in patients with kidney disease. Dose adjustment of AUGEOZ 1000MG/125MG INJECTION may be needed. Please consult your doctor.
AUGEOZ 1000MG/125MG INJECTION is probably safe to use in patients with liver disease. Limited data available suggests that dose adjustment of AUGEOZ 1000MG/125MG INJECTION may not be needed in these patients. Please consult your doctor.